599 related articles for article (PubMed ID: 21330342)
1. Chemokine saliva levels in patients with primary Sjögren's syndrome, associated Sjögren's syndrome, pre-clinical Sjögren's syndrome and systemic autoimmune diseases.
Hernández-Molina G; Michel-Peregrina M; Hernández-Ramírez DF; Sánchez-Guerrero J; Llorente L
Rheumatology (Oxford); 2011 Jul; 50(7):1288-92. PubMed ID: 21330342
[TBL] [Abstract][Full Text] [Related]
2. [Salivary immunoglobulins in the diagnosis of primary Sjögren's syndrome].
Bianucci GF; Campana G; Maddali Bongi S; Palermo C; Castagnoli A
Minerva Med; 1993 Apr; 84(4):161-70. PubMed ID: 8506054
[TBL] [Abstract][Full Text] [Related]
3. Similarities and differences between primary and secondary Sjögren's syndrome.
Hernández-Molina G; Avila-Casado C; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín V; Soto-Abraham V; Recillas-Gispert C; Sánchez-Guerrero J
J Rheumatol; 2010 Apr; 37(4):800-8. PubMed ID: 20194453
[TBL] [Abstract][Full Text] [Related]
4. Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome.
Salliot C; Gottenberg JE; Bengoufa D; Desmoulins F; Miceli-Richard C; Mariette X
J Rheumatol; 2007 Nov; 34(11):2253-8. PubMed ID: 17937465
[TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
Tomás S; Coll J; Reth P; Corominas JM
Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
[TBL] [Abstract][Full Text] [Related]
6. The overlap of Sjögren's syndrome with other systemic autoimmune diseases.
Ramos-Casals M; Brito-Zerón P; Font J
Semin Arthritis Rheum; 2007 Feb; 36(4):246-55. PubMed ID: 16996579
[TBL] [Abstract][Full Text] [Related]
7. Predictive and prognostic value of antinuclear antibodies and rheumatoid factor in primary Sjogren's syndrome.
Huo AP; Lin KC; Chou CT
Int J Rheum Dis; 2010 Feb; 13(1):39-47. PubMed ID: 20374383
[TBL] [Abstract][Full Text] [Related]
8. Salivary and serum interleukin 6 in primary Sjögren's syndrome.
Grisius MM; Bermudez DK; Fox PC
J Rheumatol; 1997 Jun; 24(6):1089-91. PubMed ID: 9195514
[TBL] [Abstract][Full Text] [Related]
9. Serum, but Not Saliva, CXCL13 Levels Associate With Infiltrating CXCL13+ Cells in the Minor Salivary Gland Lesions and Other Histologic Parameters in Patients With Sjögren's Syndrome.
Chatzis L; Goules AV; Stergiou IE; Voulgarelis M; Tzioufas AG; Kapsogeorgou EK
Front Immunol; 2021; 12():705079. PubMed ID: 34484201
[TBL] [Abstract][Full Text] [Related]
10. Involvement of the interferon-gamma-induced T cell-attracting chemokines, interferon-gamma-inducible 10-kd protein (CXCL10) and monokine induced by interferon-gamma (CXCL9), in the salivary gland lesions of patients with Sjögren's syndrome.
Ogawa N; Ping L; Zhenjun L; Takada Y; Sugai S
Arthritis Rheum; 2002 Oct; 46(10):2730-41. PubMed ID: 12384933
[TBL] [Abstract][Full Text] [Related]
11. Salivary chemokine levels in patients with primary Sjogren's syndrome.
Lee YJ; Scofield RH; Hyon JY; Yun PY; Lee HJ; Lee EY; Lee EB; Song YW
Rheumatology (Oxford); 2010 Sep; 49(9):1747-52. PubMed ID: 20525739
[TBL] [Abstract][Full Text] [Related]
12. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome?
Baldini C; Giusti L; Bazzichi L; Lucacchini A; Bombardieri S
Autoimmun Rev; 2008 Jan; 7(3):185-91. PubMed ID: 18190876
[TBL] [Abstract][Full Text] [Related]
14. Salivary anti-spectrin autoantibodies in Sjögren's syndrome.
Moody M; Zipp M; Al-Hashimi I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):322-7. PubMed ID: 11250630
[TBL] [Abstract][Full Text] [Related]
15. Salivary resistin reflects local inflammation in Sjögren's syndrome.
Boström EA; d'Elia HF; Dahlgren U; Simark-Mattsson C; Hasséus B; Carlsten H; Tarkowski A; Bokarewa M
J Rheumatol; 2008 Oct; 35(10):2005-11. PubMed ID: 18709689
[TBL] [Abstract][Full Text] [Related]
16. Elevated IgG4 serum levels among primary Sjögren's syndrome patients: do they unmask underlying IgG4-related disease?
Mavragani CP; Fragoulis GE; Rontogianni D; Kanariou M; Moutsopoulos HM
Arthritis Care Res (Hoboken); 2014 May; 66(5):773-7. PubMed ID: 25100215
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome.
Hansen A; Reiter K; Ziprian T; Jacobi A; Hoffmann A; Gosemann M; Scholze J; Lipsky PE; Dörner T
Arthritis Rheum; 2005 Jul; 52(7):2109-19. PubMed ID: 15986367
[TBL] [Abstract][Full Text] [Related]
19. [Cell-mediated immunity in patients with Sjogren's syndrome].
Krejsek J; Slezák R; Kopecký O; Vokurková D; Loudová M; Derner V
Cas Lek Cesk; 1997 Jan; 136(2):44-7. PubMed ID: 9147852
[TBL] [Abstract][Full Text] [Related]
20. Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment.
Peluso G; De Santis M; Inzitari R; Fanali C; Cabras T; Messana I; Castagnola M; Ferraccioli GF
Arthritis Rheum; 2007 Jul; 56(7):2216-22. PubMed ID: 17599740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
